Biologically effective dose and prediction of obliteration of unruptured arteriovenous malformations treated by upfront Gamma Knife radiosurgery: a series of 149 consecutive cases.

Details

Ressource 1Request a copy Under indefinite embargo.
UNIL restricted access
State: Public
Version: Final published version
License: All rights reserved
Serval ID
serval:BIB_27B9060C5437
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Biologically effective dose and prediction of obliteration of unruptured arteriovenous malformations treated by upfront Gamma Knife radiosurgery: a series of 149 consecutive cases.
Journal
Journal of neurosurgery
Author(s)
Tuleasca C., Peciu-Florianu I., Leroy H.A., Vermandel M., Faouzi M., Reyns N.
ISSN
1933-0693 (Electronic)
ISSN-L
0022-3085
Publication state
Published
Issued date
24/07/2020
Peer-reviewed
Oui
Volume
134
Number
6
Pages
1901-1911
Language
english
Notes
Publication types: Journal Article
Publication Status: epublish
Abstract
Arteriovenous malformations (AVMs) present no pathologic tissue, and radiation dose is confined in a clear targeted volume. The authors retrospectively evaluated the role of the biologically effective dose (BED) after Gamma Knife radiosurgery (GKRS) for brain AVMs.
A total of 149 consecutive cases of unruptured AVMs treated by upfront GKRS in Lille University Hospital, France, were included. The mean length of follow-up was 52.9 months (median 48, range 12-154 months). The primary outcome was obliteration, and the secondary outcome was complication appearance. The marginal dose was 24 Gy in a vast majority of cases (n = 115, 77.2%; range 18-25 Gy). The mean BED was 220.1 Gy2.47 (median 229.9, range 106.7-246.8 Gy2.47). The mean beam-on time was 32.3 minutes (median 30.8, range 9-138.7 minutes). In the present series, the mean radiation dose rate was 2.259 Gy/min (median 2.176, range 1.313-3.665 Gy/min). The Virginia score was 0 in 29 (19.5%), 1 in 61 (40.9%), 2 in 41 (27.5%), 3 in 18 (12.1%), and 4 in 0 (0%) patients, respectively. The mean Pollock-Flickinger score was 1.11 (median 1.52, range 0.4-2.9). Univariate (for obliteration and complication appearance) and multivariate (for obliteration only) analyses were performed.
A total of 104 AVMs (69.8%) were obliterated at the last follow-up. The strongest predictor for obliteration was BED (p = 0.03). A radiosurgical obliteration score is proposed, derived from a fitted multivariable model: (0.018 × BED) + (1.58 × V12) + (-0.013689 × beam-on time) + (0.021 × age) - 4.38. The area under the receiver operating characteristic curve was 0.7438; after internal validation using bootstrap methods, it was 0.7088. No statistically significant relationship between radiation dose rate and obliteration was found (p = 0.29). Twenty-eight (18.8%) patients developed complications after GKRS; 20 (13.4%) of these patients had transient adverse radiological effects (perilesional edema developed). Predictors for complication appearance were higher prescription isodose volume (p = 0.005) and 12-Gy isodose line volume (V12; p = 0.001), higher Pollock-Flickinger (p = 0.02) and Virginia scores (p = 0.003), and lower beam-on time (p = 0.03).
The BED was the strongest predictor of obliteration of unruptured AVMs after upfront GKRS. A radiosurgical score comprising the BED is proposed. The V12 appears as a predictor for both efficacy and toxicity. Beam-on time was illustrated as statistically significant for both obliteration and complication appearance. The radiation dose rate did not influence obliteration in the current analysis. The exact BED threshold remains to be established by further studies.
Keywords
Adolescent, Adult, Aged, Arteriovenous Fistula/diagnosis, Arteriovenous Fistula/epidemiology, Arteriovenous Fistula/radiotherapy, Female, Follow-Up Studies, France/epidemiology, Humans, Intracranial Arteriovenous Malformations/diagnosis, Intracranial Arteriovenous Malformations/epidemiology, Intracranial Arteriovenous Malformations/radiotherapy, Male, Middle Aged, Predictive Value of Tests, Radiation Dosage, Radiosurgery/methods, Retrospective Studies, Treatment Outcome, Young Adult, Gamma Knife, biologically effective dose, obliteration, score, stereotactic radiosurgery, vascular disorders
Pubmed
Web of science
Funding(s)
University of Lausanne / CRND-31188
Create date
29/07/2020 20:57
Last modification date
14/03/2023 7:50
Usage data